Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on April 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

High-Throughput Screening Platform Integration

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334510
New
Federal
6515--ForeSite SS Tablet w/Pressure Mapping Sensor System
Solicitation # 36C24827Q0082
The Department of Veterans Affairs, through Network Contracting Office 8, is conducting market research via a Sources Sought Notice to identify authorized sources for the ForeSite SS Tablet Pressure Mapping System manufactured by ForeSite Medical. This effort is for acquisition planning purposes and is not a formal solicitation. The required system is intended for clinical pressure assessment and treatment and must include the tablet platform, pressure-mapping sensors, sensor packs, chargers, software licenses, cables, and all necessary accessories. Key functional requirements include real-time pressure analysis and visualization, patient data storage and reporting, wireless and wired connectivity, and portable battery-powered operation. All equipment must be new and include the manufacturer's standard warranty. Interested vendors must submit electronic responses in PDF or Word format by October 30, 2026. Submissions must include the company name, address, Unique Entity Identifier, point of contact, and business size or socioeconomic status, such as SDVOSB, VOSB, Small Business, or Large Business. Additionally, respondents must provide documentation proving they are authorized to distribute or resell the ForeSite system, an estimated delivery lead time, and confirmation regarding the new condition and warranty of the product. The place of performance is located in Tampa, Florida, under NAICS code 334510.
248-NETWORK Contract Office 8 (36C248)

POSTED

about 12 hours ago

DEADLINE

in 3 days
NAICS: 334510
New
Federal
Electro-Therapeutic Modalities for Pain Management (ETMPM) - Transcutaneous Electrical Nerve Stimulation (TENS) Procurement Program
Solicitation # 36C79126R0011
The Department of Veterans Affairs is soliciting proposals under Solicitation Number 36C79126R0011 to establish multiple single-award, Firm-Fixed-Price, Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for the Electro-Therapeutic Modalities for Pain Management (ETMPM) and Transcutaneous Electrical Nerve Stimulation (TENS) Procurement Program. This national program provides FDA-cleared electro-therapeutic devices and accessories to support non-opioid pain management across 168 VA Medical Centers and over 1,000 Community Based Outpatient Clinics. The scope includes portable TENS units, Interferential Current (IFC) devices, thermal and non-thermal Short-Wave Diathermy (SWD) devices, and portable neuromodulation systems for headache disorders, along with associated consumables such as electrodes, lead wires, and chargers. The procurement utilizes a VA Tiered Set-Aside Evaluation Approach, prioritizing Service-Disabled Veteran-Owned Small Businesses (Tier 1), followed by Veteran-Owned Small Businesses (Tier 2), other small business concerns (Tier 3), and finally other-than-small business concerns (Tier 4). Award methodology varies by item: CLINs X001 through X004 are evaluated based on Lowest Price Technically Acceptable (LPTA) procedures, while CLIN X005 is evaluated using a Best Value Tradeoff method, weighting technical factors at 60 percent, price at 25 percent, and past performance at 15 percent. Responsive proposals must include a signed SF 1449, a Technical Capability Statement, FDA 510(k) clearance letters, and three recent past performance documents. Non-manufacturers must provide OEM-issued Authorized Distributor Letters. Mandatory certifications include the Price Matrix, Limitations on Subcontracting, and either the Buy American Certificate (for small businesses) or the Trade Agreements Certificate (for large businesses). Product samples for every offered item must be shipped to the Denver Logistics Service facility. Following several amendments, the final deadline for the receipt of all proposal documentation and product samples is November 2, 2026, at 12:00 PM CDT.
Commodities & Services Acquisition Service (36C791)

POSTED

1 day ago

DEADLINE

in 6 days
NAICS: 334510
New
Federal
Scanner Ultrasonic Ocular
Solicitation # W91CRB-26-AWSP-Scanner-Ultrasonic-Ocular-RPP
The Portfolio Acquisition Executive Maneuver Ground, Project Manager Maneuver Medical Systems is soliciting prototype proposals for Scanner Ultrasonic Ocular devices under Other Transaction Authority pursuant to 10 U.S.C. 4022. The objective is to identify and award two prototype agreements to procure FDA-approved commercial off-the-shelf or non-developmental item solutions that require minimal to no modification. Selected awardees must deliver four prototype devices for operational and environmental testing, including ruggedized transport cases meeting MIL-STD-810H standards. The estimated period of performance is twelve months, with awards expected in FY27 Q1 and prototype delivery required within 45 to 60 days after award. This procurement is not a FAR-based solicitation and utilizes a comparative best-fit methodology for award, prioritizing technical approach, maturity, performance compliance, reliability, schedule realism, and past performance over cost. Proposals must be submitted in four volumes by November 3, 2026, and include a Trade Agreements Act certificate and SAM.gov registration. Technical requirements include compliance with Critical Operational Device Specifications for ocular trauma imaging and adherence to NIST SP 800-171 for handling Controlled Unclassified Information. The system must operate as a standalone device without connecting to Department of War networks.
W6QK Acc-Apg

POSTED

1 day ago

DEADLINE

in 16 days

AI Contract Overview

Show more

The contract seeks the supply or integration of scalable and automated platforms designed for high-throughput neuromuscular junction (NMJ) assays specifically used in botulinum neurotoxin (BoNT) potency testing. These platforms may include multi-well or microfluidic systems that incorporate integrated data analysis capabilities, ensuring efficient and precise screening processes. The goal is to enhance testing throughput and accuracy in BoNT potency evaluation, supporting advanced research or quality control needs. Issued by the Department of Health and Human Services under the BARDA office, this subcontract opportunity was posted on April 20, 2026, with responses due by May 11, 2026. The work's location is specified as Washington, and it falls under the NAICS code 334510, which relates to semiconductor and other electronic component manufacturing, likely reflecting the technical nature of the platforms sought. The contract emphasizes delivering cutting-edge assay technology with robust data integration to support health and biodefense initiatives.

General Info

Supply automated, scalable platforms for high-throughput NMJ assays in BoNT potency testing.

NAICS

334510 - Electromedical and Electrotherapeutic Apparatus Manufacturing

Place of Performance

Washington, DC, USA

Set-Aside

NONE

Documents

This scope was carved out of SSN-BARDA-04202026.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

RRPV BoNT-NMJ

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply or integrate scalable, automated platforms capable of high-throughput NMJ assays for BoNT potency testing, including multi-well or microfluidic systems with integrated data analysis.

More opportunities from Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

Same awarding agency

NAICS: 541714
New
Federal
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Solicitation # 75A50126R00001_RFP_NPIVS_27
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. The objective is to maintain a permanent readiness posture against high-threat influenza and other viruses with pandemic potential. Selected contractors will provide vaccines, antigens, and adjuvants, and generate necessary analytical, nonclinical, clinical, and chemistry, manufacturing, and controls data for FDA submission to support rapid regulatory decisions. To be eligible, offerors must produce vaccines against influenza strains with pandemic potential and demonstrate successful manufacturing experience by holding a U.S. influenza vaccine license or having submitted a Biologics License Application for a seasonal or pandemic influenza vaccine. The government intends to award contracts to four offerors based on the Highest Technically Rated Offerors with a Fair and Reasonable Price methodology. Evaluation factors include capabilities, past performance, and price, with capabilities being the most significant. The contract structure consists of a 60-month base period and a 60-month option period, with a minimum guarantee of 50,000 dollars. Key requirements include the development of comprehensive manufacturing, business continuity, and supply continuity plans, as well as adherence to strict ASPR security and FDA CGMP standards. Performance will be managed through individual task orders and BPA call orders, with invoicing conducted quarterly via the Department of Treasury Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 24 days
View Details
NAICS: 334510
Federal
Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture Detection
Solicitation # BARDA-FY27-10192026
The Center for Biomedical Advanced Research and Development Authority (BARDA) has issued Sources Sought Notice BARDA-FY27-10192026 to identify innovative medical countermeasure technologies for the rapid triage of musculoskeletal injuries, such as fractures and soft tissue injuries of extremities. This request for information is intended for planning and market research purposes to assess commercially available or nearing-commercial technologies that utilize Super Intelligence (SI) and machine learning for automated ultrasound-based fracture detection. The goal is to find standalone, point-of-care devices that can operate in emergency departments, urgent care centers, and austere field settings without relying on traditional imaging infrastructure like X-ray or CT scans. The desired technology must feature automated volumetric capture, 3D-rotatable modeling, and SI-enabled image processing that outperforms human imaging experts and has undergone FDA 510k clearance processes. BARDA is interested in ruggedized, portable units with sufficient battery life for disaster response, interoperability with electronic health record systems, and minimal training requirements for non-specialist operators. Potential acquisition strategies being explored include direct purchases, leases, or vendor-managed inventory arrangements. Interested small businesses and other than small business concerns under NAICS code 334510 must submit their capabilities statements by 1:00 p.m. Eastern Time on November 18, 2026. Submissions must include separate Technical and Business Representation sections, each limited to 10 pages in 12-point Times New Roman font, and be emailed to Justin Moore and Richard Hall. Responses should detail the company's manufacturing capabilities within the United States, regulatory maturity, supply chain resilience, and cybersecurity standards for handling sensitive patient health information.
Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

8 days ago

DEADLINE

in 22 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS